Summary
Overview
Work History
Education
Publications
Timeline
Generic

Sheena Suthen

Summary

Results-driven healthcare professional with 5 years of experience in research, strategy development, and market access. Proven track record of developing and executing successful market access strategies to optimize product value, drive market penetration, and ensure patient access to innovative therapies. Excel at leveraging data-driven insights to interpret market trends, develop value propositions, and targeted solutions for client products. Skilled in independently handling client meetings and addressing challenging inquiries with precision and professionalism. Experienced in leadership roles, providing guidance and mentorship to colleagues, including senior team members. Committed to driving positive outcomes for patients and stakeholders. Seeking a position that challenges me to further develop leadership skills and contribute to a dynamic environment focused on optimizing healthcare outcomes, market access, and product/brand development.

Overview

5
5
years of professional experience

Work History

Project Manager, Market Access

ASIA PACIFIC MEDICAL TECHNOLOGY ASSOCIATION
09.2024 - Current
  • Led the development and execution of the Market Access Committee's agenda, aligning with organizational goals and delivering measurable outcomes.
  • Engaged with payors, policymakers, healthcare providers, and regional stakeholders to drive committee objectives and strengthen market access initiatives.
  • Conducted research to address policy gaps, authoring white papers and reports to support decision-making and advocacy efforts.
  • Monitored policy changes and reimbursement trends, providing strategic insights and recommendations to guide leadership and committee priorities.

Senior Analyst, Market Access

ANSEA HEALTHCARE CONSULTING
07.2023 - 06.2024
  • Led a successful stakeholder engagement training workshop to members of an integrated special access program (“iSAP”) in Cebu, Philippines.
  • Developed a structured risk-sharing agreement framework for a renal dialysis product, targeting both national payers and clinic providers.
  • Prepared abstracts based on an economic model created previously, resulting in acceptance at 2 prestigious Asia-Pacific congresses and a manuscript for submission to the Philippine Journal of Ophthalmology.
  • Co-led the successful development and winning of projects.
  • Managed stakeholder relationships skillfully and led client meetings throughout all projects with positive feedback from clients.
  • Assisted with business development activities such as customer review meetings, change management policies and costing reviews

Analyst, Market Access

ANSEA HEALTHCARE CONSULTING
09.2022 - 06.2023
  • Created an economic model analysing the costs of client’s treatment versus standard treatment options for glaucoma patients over a 5-year period from the perspective of a private patient in the Philippines and Vietnam.
  • Authored (co-first author) a policy whitepaper on the value assessment framework for HTA in diagnostics, with applications in two heart disease areas.
  • Designed a worked example on the application of the Australia Medical Services Advisory Committee’s (MSAC) linked evidence approach for evaluating diagnostics in HTA.
  • Experienced in competitor landscape assessment and translating complex scientific information into compelling value propositions.
  • Analysed and synthesized secondary and primary research, created detailed discussion guides and conducted over 30+ primary interviews with key opinion leaders across APAC and globally, including healthcare providers, patients, policy advisors and industry experts.

Executive, Research Office (Strategy)

SINGAPORE GENERAL HOSPITAL
03.2022 - 08.2022
  • Implemented and executed effective strategies for collaborative research initiatives between clinicians and scientific researchers.
  • Collaborated with crucial hospital stakeholders to drive the initiation, adoption, and seamless implementation of approved research strategies, involving departments such as HR, IT, Legal, Finance, the Chief Operations Officer, Chief Finance Officer, and Chairman of the Medical Board.

Research Officer

SINGHEALTH TRANSLATIONAL IMMUNOLOGY INSTITUTE
11.2019 - 02.2022
  • Authored (co-first author) a scientific manuscript for Hepatology journal (Top 5 journals for liver related research), focusing on the multidimensional analysis of the immune microenvironment in hepatocellular carcinoma: biomarker and therapeutic discovery.
  • Utilized statistical and analytical tools like R script, Prism, and Excel to analyse research data, derive meaningful insights, troubleshoot data issues, and draw conclusions.
  • Collaborated with internal teams and external partners to facilitate research projects, while meticulously preparing comprehensive reports and presentations documenting research methodologies, findings, and actionable recommendations.
  • Laboratory skills: Cytometry Time of Flight (CyTOF), Flow cytometry, Multiplexed immunohistochemistry (mIHC) using Vectra Imaging System, Luminex, Blood and tumour processing, In-vitro culture assays.

Education

Bachelor of Science - Life Sciences (Hons)

National University of Singapore
01-2019

Publications

Champion D, Suthen S, Jha A, Bourcet A. Value of In-vitro diagnostics in APAC: Value Assessment Framework with Applications for Coronary Artery Disease and Heart Failure [Internet]. 2023.


Suthen, S., Lim, C. J., Nguyen, P. H., Dutertre, C., Lai, H. L., Wasser, M., … Chew, V. (2022). Hypoxia‐driven immunosuppression by Treg and type‐2 conventional dendritic cells in HCC. Hepatology, 76(5), 1329–1344. doi:10.1002/hep.32419


Nguyen, P. H., Wasser, M., Tan, C. T., Lim, C. J., Lai, H. L., Seow, J. J., DasGupta, R., Phua, C. Z., Ma, S., Yang, J., Suthen, S.,… Chew, V. (2022). Trajectory of immune evasion and cancer progression in hepatocellular carcinoma. Nature Communications, 13(1). https://doi.org/10.1038/s41467022-29122-w


Chuah, S., Lee, J., Song, Y., Kim, H.-D., Wasser, M., Kaya, N. A., Bang, K., Lee, Y. J., Jeon, S. H., Suthen, S., … Chew, V. (2022). Uncoupling immune trajectories of response and adverse events from anti-PD-1 Immunotherapy in hepatocellular carcinoma. Journal of Hepatology, 77(3), 683–694.

https://doi.org/10.1016/j.jhep.2022.03.039

Timeline

Project Manager, Market Access

ASIA PACIFIC MEDICAL TECHNOLOGY ASSOCIATION
09.2024 - Current

Senior Analyst, Market Access

ANSEA HEALTHCARE CONSULTING
07.2023 - 06.2024

Analyst, Market Access

ANSEA HEALTHCARE CONSULTING
09.2022 - 06.2023

Executive, Research Office (Strategy)

SINGAPORE GENERAL HOSPITAL
03.2022 - 08.2022

Research Officer

SINGHEALTH TRANSLATIONAL IMMUNOLOGY INSTITUTE
11.2019 - 02.2022

Bachelor of Science - Life Sciences (Hons)

National University of Singapore
Sheena Suthen